echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > How to interpret CTD-ILD, 2018 Edition Expert Consensus (next paragraph)?

    How to interpret CTD-ILD, 2018 Edition Expert Consensus (next paragraph)?

    • Last Update: 2020-07-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    To help standardize the clinical diagnosis and treatment of ctd-ild in China, and improve the prognosis and quality of life of ctd-ild patients.how to diagnose and treat the previous ctd-ild? The contents of screening, diagnosis and disease progress assessment of connective tissue disease-related interstitial lung disease (ctd-ild) will be interpreted in the 2018 expert consensus (Part I). This issue will continue with the previous issue, focusing on the interpretation of relevant treatment and long-term management.01. Seven recommendations for the diagnosis and treatment of ctd-ild (Continued) ■ the treatment goal of ctd-ild is to achieve the double goals of CTD and ILD, but there is no recognized standard for clinical disease.however, the expert group still believes that it is necessary to initially formulate operable and applicable standards based on the existing research data and treatment experience, so as to provide clinicians with relatively standardized and consistent treatment strategies in treatment.the criteria for ILD treatment formulated by the expert group: firstly, according to the chest HRCT features and treatment response of the patients, determine whether the main lesions of ILD are reversible.the treatment objectives of reversible and irreversible lesions are shown in Table 1: the treatment objectives of ctd-ild. The treatment principles of ctd-ild are early, standardized and individualized treatment, and appropriate use of anti fibrosis drugs.the treatment strategy of ctd-ild is shown in Table 2: the treatment strategy of ctd-ild should emphasize the importance of immunosuppressive therapy for CTD. Some patients can try anti fibrosis therapy for ILD in time, so as to maintain the stability of lung function to the greatest extent.■ regular follow-up should be carried out during the treatment of ctd-ild, and the interval of follow-up depends on the progress of the disease ■ in addition to the education of disease-related knowledge, other multidisciplinary guidance is also very important. The summary of recommendation opinions and the key points of recommendation strength are shown in Table 3: Table 3: consensus recommendations 02. Six problems to be solved and new progress in diagnosis and treatment are combined by expert group For the research results and development trend in the field of ctd-ild, a prospective cohort registration database of ctd-ild should be established on the basis of national multi center and multi-disciplinary cooperation, so as to further carry out evidence-based medicine and real-world clinical research, and solve the following important problems in clinical practice.with the deepening understanding of ctd-ild, it is necessary to further refine and standardize the clinical practice of screening, diagnosis, evaluation and treatment, and promote the clinical consensus of multidisciplinary cooperation and standardized diagnosis and treatment, which will help to improve our country The level of diagnosis and treatment of ctd-ild can promote the establishment and follow-up of multi center and prospective clinical cohort, and help to solve many problems that are still unclear.further research on the pathogenesis of CTD and pulmonary interstitial fibrosis will help to promote the emergence of new therapeutic targets and the gradual introduction of new therapeutic drugs into clinical application, which will bring more choices and hopes for improving the long-term prognosis of ctd-ild patients.References: rheumatology related pulmonary vascular / interstitial disease group of Rheumatology and Immunology branch of Chinese Medical Doctor Association, etc. Chinese Journal of internal medicine.2018; 57 (8): 558-565-end-love me, please give me a good look!
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.